Specialty drugs constitute an ever-growing share of the nation’s overall drug spend while being something that many patients absolutely depend on for treatment and management of disease. Access and affordability are also eternal issues in the specialty pharma world.
In late April, Walgreens announced that it was expanding its specialty pharmacy business and launching cell and gene therapy services, so it made sense to have a conversation with Tracey James, who leads the retailer’s specialty pharmacy business. Below is our second episode of Season 2, which focuses on the evolution of pharmacies and PBMs.
